Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Capstone Copper
AN
AnalystHighTarget
Consensus Narrative from 16 Analysts
Santo Domingo And Global Electrification Will Strengthen Domestic Copper Supply
Key Takeaways Strong operational execution and asset optimization are driving production and margin upside, positioning Capstone for meaningful earnings and revenue growth. Strategic U.S. positioning and robust organic growth pipeline enable Capstone to capture benefits from government policy shifts and long-term copper demand trends.
View narrative
CA$13.00
FV
28.8% undervalued
intrinsic discount
25.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Shaver Shop Group
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Rising Grooming Trends And Digital Adoption Will Broaden Market Appeal
Key Takeaways Expanding exclusive brands and digital innovation could transform the business model, driving higher margins and establishing dominance in premium grooming. Demographic trends, omni-channel expansion, and social-driven grooming habits position the company for resilient, compounding growth and above-market revenue gains.
View narrative
AU$1.85
FV
17.6% undervalued
intrinsic discount
5.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
JHSF Participações
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Brazilian Affluence Will Spur Premium Mixed-Use Developments Despite Risks
Key Takeaways Rapid growth in high-margin recurring revenue and synergy across luxury segments strengthens pricing power, margin improvement, and earnings stability beyond analyst expectations. Strong balance sheet and exclusive assets position JHSF for robust growth, asset appreciation, and expansion through market cycles and evolving luxury demand trends.
View narrative
R$10.00
FV
44.7% undervalued
intrinsic discount
14.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Foxtons Group
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
London Urbanisation And Tech Adoption Will Secure Market Leadership
Key Takeaways Operational efficiencies, tech advancements, and strategic acquisitions position Foxtons for margin expansion and market share gains beyond current expectations. Strong relationships with institutional landlords and favorable housing dynamics support high-margin, recurring income and resilient, sustainable growth.
View narrative
UK£1.03
FV
45.2% undervalued
intrinsic discount
6.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Greenyard
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Rising Plant-Based Diets And Urban Lifestyles Will Create Market Opportunities
Key Takeaways Leadership in integrated partnerships, sustainability, and healthy product trends should drive market share gains, premium pricing power, and long-term revenue growth. Deep operational restructuring, digitalization, and focus on value-added innovation could enable best-in-class profitability and resilient earnings.
View narrative
€7.50
FV
1.9% undervalued
intrinsic discount
4.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Metrovacesa
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Urbanization And Green Building Will Drive Lasting Value
Key Takeaways Flexible sales strategy, sustainability focus, and proptech integration position Metrovacesa for margin expansion, premium pricing, and improved operational efficiency. Strategic land assets and entry into rental and flexible living segments enable diversified, resilient income and greater institutional investment attraction.
View narrative
€11.80
FV
14.4% undervalued
intrinsic discount
12.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Medexus Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Aging Populations And Regulatory Tailwinds Will Expand Specialty Therapies
Key Takeaways Rapid adoption of GRAFAPEX and strong orphan drug positioning are set to elevate Medexus's gross margins and accelerate earnings growth across its portfolio. Medexus is poised for above-industry, long-term growth by leveraging demographic shifts, business development, and regulatory advantages supporting expansion in rare and chronic disease therapies.
View narrative
CA$8.00
FV
64.4% undervalued
intrinsic discount
14.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
CYD
China Yuchai International
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Alternative Fuel Expansion Will Strengthen Demand In Emerging Markets
Key Takeaways Expansion in high-horsepower engines, emerging markets, and alternative fuels positions the company for market share gains and structurally higher margins. Improved supply chain efficiency and strong OEM relationships are set to enhance profitability and create a stable, recurring revenue base.
View narrative
US$27.99
FV
10.4% overvalued
intrinsic discount
11.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Descartes Systems Group
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Global Trade Trends Will Drive Agile Logistics Platforms
Key Takeaways Leadership in real-time logistics visibility and global trade compliance is accelerating adoption, boosting recurring revenue, and expanding Descartes' market reach and pricing power. Strategic acquisitions and advanced AI integration are strengthening cross-selling, reducing customer churn, and driving sustained earnings growth with expanding margins.
View narrative
CA$174.72
FV
22.0% undervalued
intrinsic discount
11.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies